Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 28Lung Neoplasms 27Neoplasm Metastasis 26Carcinoma, Non-Small-Cell Lung 21Multiple Myeloma 18Urinary Bladder Neoplasms 16Breast Neoplasms 16Lymphoma 15Glioma 14Colorectal Neoplasms 14Pancreatic Neoplasms 13Lymphoma, Large B-Cell, Diffuse 13Carcinoma, Renal Cell 13Squamous Cell Carcinoma of Head and Neck 12Ovarian Neoplasms 12Melanoma 12Triple Negative Breast Neoplasms 11Glioblastoma 10Oropharyngeal Neoplasms 9Mouth Neoplasms 9Fallopian Tube Neoplasms 9Carcinoma 9Sarcoma 8Lymphoma, Non-Hodgkin 8Endometrial Neoplasms 8Carcinoma, Transitional Cell 8Medulloblastoma 7Lymphoma, Follicular 7Laryngeal Neoplasms 7Carcinoma, Hepatocellular 7

Interventions

ribociclib 2Specimen Handling 2tucatinib 1trastuzumab biosimilar HLX02 1pertuzumab 1exemestane 1durvalumab 1Trastuzumab 1Taxes 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunoglobulin G 1Genetic Testing 1Fulvestrant 1Drug Therapy 1Doxorubicin 1Docetaxel 1Disulfides 1Cyclophosphamide 1Carboplatin 1Anastrozole 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage II Breast Cancer AJCC v8 × Magnetic Resonance Spectroscopy × 30 days × Clear all
NCT07391774 2026-05-13

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
1,978 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡